Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors

Neuron

Volumn 65, Issue 1, 2010, Pages 135-142

  Voon, Valerie ^a   Pessiglione, Mathias ^b   Brezing, Christina ^a   Gallea, Cecile ^a   Fernandez, Hubert H ^c   Dolan, Raymond J ^d   Hallett, Mark ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ARTICLE; ASSOCIATION; COMPULSION; CONTROLLED STUDY; CORPUS STRIATUM; DECISION MAKING; DISEASE PREDISPOSITION; HUMAN; LEARNING; MENTAL PERFORMANCE; NEUROMODULATION; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; REINFORCEMENT;

BIAS (EPIDEMIOLOGY); CHOICE BEHAVIOR; COMPULSIVE BEHAVIOR; CORPUS STRIATUM; DOPAMINE; GAMBLING; HUMANS; LEARNING; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; REINFORCEMENT (PSYCHOLOGY); REWARD;

EID: 73549113279     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.12.027     Document Type: Article

References (30)

1. Bayer H.M., and Glimcher P.W. Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron 47 (2005) 129-141
2. Berthet A., Porras G., Doudnikoff E., Stark H., Cador M., Bezard E., and Bloch B. Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J. Neurosci. 29 (2009) 4829-4835
3. Dagher A., and Robbins T.W. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 61 (2009) 502-510
4. Daw N.D., Kakade S., and Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 15 (2002) 603-616
5. Dolan R.J. The human amygdala and orbital prefrontal cortex in behavioural regulation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362 (2007) 787-799
6. Duvernoy H.M. The Human Brain Surface, Three Dimensional Sectional Anatomy with MRI, and Blood Supply (1999), Springer, New York
7. Evans A.H., Pavese N., Lawrence A.D., Tai Y.F., Appel S., Doder M., Brooks D.J., Lees A.J., and Piccini P. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann. Neurol. 59 (2006) 852-858
8. Frank M.J., Seeberger L.C., and O'Reilly R.C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306 (2004) 1940-1943
9. Frank M.J., Moustafa A.A., Haughey H.M., Curran T., and Hutchison K.E. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc. Natl. Acad. Sci. USA 104 (2007) 16311-16316
10. Frank M.J., Samanta J., Moustafa A.A., and Sherman S.J. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 318 (2007) 1309-1312
11. Genovese C.R., Lazar N.A., and Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15 (2002) 870-878
12. Goudriaan A.E., Oosterlaan J., de Beurs E., and van den Brink W. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res. Cogn. Brain Res. 23 (2005) 137-151
13. Hobson D.E., Lang A.E., Martin W.R., Razmy A., Rivest J., and Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287 (2002) 455-463
14. Lomanowska A., Gormley S., and Szechtman H. Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole. Pharmacol. Biochem. Behav. 77 (2004) 617-622
15. McElroy S.L., Keck P.E., Pope H.G., Smith J.M., and Strakowski S.M. Compulsive buying: a report of 20 cases. J. Clin. Psychiatry 55 (1994) 242-248
16. O'Doherty J.P., Dayan P., Friston K., Critchley H., and Dolan R.J. Temporal difference models and reward-related learning in the human brain. Neuron 38 (2003) 329-337
17. Pessiglione M., Seymour B., Flandin G., Dolan R.J., and Frith C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442 (2006) 1042-1045
18. Petry N.M. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J. Abnorm. Psychol. 110 (2001) 482-487
19. Redish A.D. Addiction as a computational process gone awry. Science 306 (2004) 1944-1947
20. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1593-1599
21. Seymour B., O'Doherty J.P., Dayan P., Koltzenburg M., Jones A.K., Dolan R.J., Friston K.J., and Frackowiak R.S. Temporal difference models describe higher-order learning in humans. Nature 429 (2004) 664-667
22. Seymour B., O'Doherty J.P., Koltzenburg M., Wiech K., Frackowiak R., Friston K., and Dolan R. Opponent appetitive-aversive neural processes underlie predictive learning of pain relief. Nat. Neurosci. 8 (2005) 1234-1240
23. Steeves T.D., Miyasaki J., Zurowski M., Lang A.E., Pellecchia G., Van Eimeren T., Rusjan P., Houle S., and Strafella A.P. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132 (2009) 1376-1385
24. Sutton R.S., and Barto A.G. Reinforcement learning: an introduction (1998), MIT Press, Cambridge, MA
25. van Eimeren T., Ballanger B., Pellecchia G., Miyasaki J.M., Lang A.E., and Strafella A.P. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: A trigger for pathological gambling in Parkinson's disease?. Neuropsychopharmacology 34 (2009) 2758-2766
26. Voon V., and Fox S.H. Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch. Neurol. 20 (2007) 484-492
27. Voon V., Potenza M.N., and Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr. Opin. Neurol. 20 (2007) 484-492
28. Voon V., Fernagut P.O., Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos J.L., Obeso J.A., and Bezard E. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol. 8 (2009) 1140-1149
29. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., Moberg P.J., and Stern M.B. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch. Neurol. 63 (2006) 969-973
30. Zernig G., Ahmed S.H., Cardinal R.N., Morgan D., Acquas E., Foltin R.W., Vezina P., Negus S.S., Crespo J.A., Stöckl P., et al. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80 (2007) 65-119